Tenon Medical Inc-28 (TNONW) — Smart Money Tracker (13F, Q2 2026)

TNONW ranks #10294 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

TNONW is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

9 institutions disclose a position in TNONW, but none treat it as a major bet — even Focus Partners Wealth, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

TNONW reported a net loss of $13.7M over the trailing twelve months.

• Not yet profitable — net loss of $13.7M over the trailing twelve months
• Revenue grew 80.3% year over year
• Net income declined year over year, from -$12.7M to -$13.7M
• Operating cash flow was negative, using $10.7M in cash
• Current ratio of 2.11x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.13x equity — within a conventional range